Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.
Cell Transplant. 2009;18(7):691-3. doi: 10.3727/096368909X470883. Epub 2009 Sep 28.
A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance from the laboratory to the clinic.
一个由多个学术机构和生物技术公司的转化干细胞和中风专家组成的联盟，在政府（FDA/NIH）的指导下，正在缺失。在这里，如果细胞疗法要从实验室推进到临床，我们就必须建立这样一个联盟。
